Li_2022_RSC.Adv_12_35477

Reference

Title : A carboxylesterase-activatable near-infrared phototheranostic probe for tumor fluorescence imaging and photodynamic therapy - Li_2022_RSC.Adv_12_35477
Author(s) : Li L , Zhang Q , Li J , Tian Y , Liu W , Diao H
Ref : RSC Adv , 12 :35477 , 2022
Abstract :

Phototheranostic probes have been proven to be a promising option for cancer diagnosis and treatment. However, near-infrared phototheranostic probes with specific tumor microenvironment responsiveness are still in demand. In this paper, a carboxylesterase (CES)-responsive near-infrared phototheranostic probe was developed by incorporating 6-acetamidohexanoic acid into a hemicyanine dye through an ester bond. The probe exhibits highly sensitive and selective fluorescence enhancement towards CES because CES-catalyzed cleavage of the ester bond leads to the release of the fluorophore. By virtue of its near-infrared analytical wavelengths and high sensitivity, the probe has been employed for endogenous CES activatable fluorescence imaging of tumor cells. Moreover, under 660 nm laser irradiation, the probe can generate toxic reactive oxygen species and efficiently kill tumor cells, with low cytotoxicity in dark. As far as we know, the probe was the first CES-responsive phototheranostic probe with both near-infrared analytical wavelengths and photosensitive capacity, which may be useful in the real-time and in situ imaging of CES as well as imaging-guided photodynamic therapy of tumors. Therefore, the proposed probe may have wide application prospect in cancer theranostics.

PubMedSearch : Li_2022_RSC.Adv_12_35477
PubMedID: 36540215

Related information

Citations formats

Li L, Zhang Q, Li J, Tian Y, Liu W, Diao H (2022)
A carboxylesterase-activatable near-infrared phototheranostic probe for tumor fluorescence imaging and photodynamic therapy
RSC Adv 12 :35477

Li L, Zhang Q, Li J, Tian Y, Liu W, Diao H (2022)
RSC Adv 12 :35477